Literature DB >> 11850798

Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene.

Yehenew Agazie1, Irene Ischenko, Michael Hayman.   

Abstract

V-SEA is the transforming component of S13 Avian Erythroblastosis Retrovirus that causes erythroblastosis and anemia in chicken. Like all members in the family (MET, RON, SEA), its cytosolic domain possesses two tyrosine autophosphorylation sites in the tandemly arranged bidentate motif that serve as docking sites for SH2 domain-containing proteins. Here, we investigated phosphotyrosine-dependent activation of signaling pathways and their significance in V-SEA-induced transformation and/or proliferation. We demonstrated that V-SEA activates the PI3K-Akt signaling pathway primarily in Y557- and secondarily in Y564-dependent manner. V-SEA was also shown to induce the tyrosine phosphorylation of the Gab2 protein, leading to PI3K association and thus providing an alternative route for PI3K activation. On the other hand, activation of the Ras-ERK pathway is primarily via Y564 and secondarily via Y557. A dominant-negative form of Ras inhibited V-SEA-induced ERK phosphorylation in concentration dependent manner suggesting the importance of the Grb2-Ras signaling axis in V-SEA-induced ERK activation. The biological significance of activation of the PI3K-Akt and the Ras-ERK pathways in V-SEA-induced transformation was analysed in the V-SEA-RAT1 and V-SEA-3T3 cell lines by employing specific inhibitors, LY294002 and PD98059 compounds. Both the PD and LY compounds inhibited cell growth, but only the PD compound caused reversion of the transformed phenotype. In addition, both compounds inhibited focal colony formation by the transformants in soft agar. Thus, transformation by the V-SEA oncogene is a function of the concomitant activation of, at least, the PI3K-Akt and Ras-ERK signaling pathways that regulate cell growth and morphology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850798     DOI: 10.1038/sj.onc.1205115

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  4 in total

1.  Differential effects of interferon alpha-2b and beta on the signaling pathways in human liver cancer cells.

Authors:  Kazuya Matsumoto; Jun-ichi Okano; Yoshikazu Murawaki
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

2.  Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination.

Authors:  Fekadu Kassie; Tamene Melkamu; Abaineh Endalew; Pramod Upadhyaya; Xianghua Luo; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2010-07-05       Impact factor: 4.944

3.  Molecular mechanism for SHP2 in promoting HER2-induced signaling and transformation.

Authors:  Xiangdong Zhou; Yehenew M Agazie
Journal:  J Biol Chem       Date:  2009-03-04       Impact factor: 5.157

4.  Hypoxia/reoxygenation stimulates proliferation through PKC-dependent activation of ERK and Akt in mouse neural progenitor cells.

Authors:  Sang Min Sung; Dae Soo Jung; Chae Hwa Kwon; Ji Yeon Park; Soo Kyung Kang; Yong Keun Kim
Journal:  Neurochem Res       Date:  2007-06-12       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.